Bafna Pharmaceuticals (India) Today

BAFNAPH -  India Stock  

INR 130.20  1.80  1.36%

Bafna Pharmaceuticals is trading at 130.20 as of the 21st of September 2021. This is a -1.36 percent down since the beginning of the trading day. The stock's open price was 132.0. Bafna Pharmaceuticals has about a 27 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Bafna Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of October 2019 and ending today, the 21st of September 2021. Click here to learn more.
 Market Performance
0 of 100
  Odds Of Distress
Less than 27
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Bafna Pharmaceuticals Stock Profile

Bafna Pharmaceuticals Limited manufactures and sells generic pharmaceutical products in India. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in India and is traded on National Stock Exchange of India. It employs 264 people. more on Bafna Pharmaceuticals
Bafna Pharmaceuticals generates negative expected return over the last 90 days
Bafna Pharmaceuticals has accumulated about 12.21 M in cash with (389.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51.
Roughly 95.0% of the company shares are held by company insiders
Legal NameBafna Pharmaceuticals
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Bafna Pharmaceuticals' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellOvervalued
Bafna Pharmaceuticals (BAFNAPH) is traded on National Stock Exchange of India in India and employs 264 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 3.28 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bafna Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Bafna Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Bafna Pharmaceuticals operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 23.66 M outstanding shares. Bafna Pharmaceuticals has accumulated about 12.21 M in cash with (389.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51.
Check Bafna Pharmaceuticals Probability Of Bankruptcy
Ownership
Bafna Pharmaceuticals holds a total of twenty-three million six hundred sixty thousand outstanding shares. Bafna Pharmaceuticals shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company outstanding shares. 95.49 percent of Bafna Pharmaceuticals outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Bafna Ownership Details

Bafna Pharmaceuticals Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Bafna Pharmaceuticals market risk premium is the additional return an investor will receive from holding Bafna Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bafna Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Bafna Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Bafna Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.

Bafna Stock Against Markets

Picking the right benchmark for Bafna Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Bafna Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Bafna Pharmaceuticals is critical whether you are bullish or bearish towards Bafna Pharmaceuticals at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bafna Pharmaceuticals without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Focused Opportunities Now

   

Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Module
Continue to Trending Equities. Note that the Bafna Pharmaceuticals information on this page should be used as a complementary analysis to other Bafna Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Tools for Bafna Stock

When running Bafna Pharmaceuticals price analysis, check to measure Bafna Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bafna Pharmaceuticals is operating at the current time. Most of Bafna Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Bafna Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bafna Pharmaceuticals' price. Additionally, you may evaluate how the addition of Bafna Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go